Love addiction and social media stalking could be frying your brain, study finds
Folks who obsess over their romantic partners — also known as 'love addiction' — were more likely to report brain fog, memory problems and trouble focusing, a new study conducted by a group of Italian researchers found.
Even the mildly lovesick felt scrambled, especially when social media was involved.
'It can certainly be psychologically, emotionally and neurologically draining,' said Dr. Marisa Cohen, a New York-based marriage and family therapist. 'They may start to experience withdrawal symptoms when removed from that person or relationship.'
The study, published in the peer-reviewed journal Behavioural Brain Research, surveyed 600 Italian adults between July 2022 and May 2023, more than 70% of whom were women, using validated, self-reported questionnaires on anxiety, depression, resilience, memory ability, attention and social media use.
Most participants were between 26 and 35 years old, and over two-thirds held a university degree.
The researchers found a clear pattern: the more someone clung to their crush, the worse their attention span became. Higher love addiction scores were linked to increased anxiety, depression and mental fatigue.
Heavy Instagram and TikTok use worsened symptoms.
'People have much easier access to this window into their [partner's] life,' Cohen said.
Scroll-happy users fueled jealousy by constantly stalking their partners online, sparking obsessive thoughts and wrecking their focus at work. Many said they felt mentally and emotionally 'off,' even while still in relationships.
Dr. Sheri Meyers, Los Angeles-based relationship expert and therapist, calls it emotional sex — a psychological 'affair of the heart' that messes with your mind.
'You begin to channel the bulk of your emotions, hopes and desires onto the other person,' Meyers said. '[It] feels like romantic love but can lead us to act in ways that are contrary to our ideals, values and relationship goals and better judgment.'
The emotional rollercoaster, from longing to jealousy to withdrawal, can throw off the brain's reward system and lead to mood swings, obsessive thinking and mental burnout, she added.
Dr. Ryan Rahm-Knigge, a Minnesota psychologist who researches compulsive sexual behavior, said while 'love addiction' isn't an official diagnosis, the study's findings echo clinical issues he sees in therapy.
'My experience is that these issues are more than heartbreak or desire,' he said. 'We see people suffering with feelings like their love pursuits or sexual behaviors or urges are out of control or in control of them.'
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Pharmacy warning of unsustainable demand for weight loss medication
The National Pharmacy Association (NPA) has issued a warning that the burgeoning demand for weight loss injections may be unsustainable, citing a significant mismatch between public interest and clinical suitability for the treatments. The NPA, which represents over 6,000 independent community pharmacies, highlighted this concern. A poll commissioned by the association revealed that 21 per cent of respondents had attempted to access weight loss treatments in the past year, either online or directly from a pharmacy. This figure surged to 35 per cent among 16 to 34-year-olds, contrasting sharply with just seven per cent of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'
Fox News
3 hours ago
- Fox News
Forget 10,000 steps — research reveals the real number you need for better health
You may not need as many steps as you thought. Ten thousand steps per day has been widely recommended as the standard benchmark for physical activity — but a new study suggests that just 7,000 could be enough to boost essential health markers. Researchers from the University of Sydney conducted a review of 57 studies spanning more than 10 countries, which tracked participants' steps and health outcomes. SIMPLE JAPANESE FITNESS TREND COULD ADD 7 YEARS TO LIFE EXPECTANCY, EXPERTS SAY Led by Professor Melody Ding from the School of Public Health, the team looked at how different daily step counts impacted the risk of dying from heart disease and cancer, as well as the risk of developing cancer, type 2 diabetes, dementia and depression, according to a university press release. They found that walking at least 7,000 steps a day was linked to improvement in eight major health outcomes, including heart disease, dementia and depressive symptoms. "Any increase in daily steps, even modest ones like 4,000 steps, delivers health benefits compared to very low activity levels," Ding told Fox News Digital. "When possible, targeting around 7,000 steps per day can substantially reduce risks for many chronic diseases and adverse health outcomes." "Even small increases in step counts, such as increasing from 2,000 to 4,000 steps a day, are associated with significant health gain." Higher step counts beyond 7,000 may add extra benefits, but the improvement rate slows, she noted. The results were published in The Lancet Public Health journal. In particular, the researchers found that walking 7,000 steps a day reduced the risk of death by 47%, almost exactly the same as 10,000 steps. That same step benchmark was also linked to a 38% reduced risk of dementia and a 22% reduced risk of type 2 diabetes, both only slightly lower than the benefit of 10,000 steps, the release stated. "Significant health improvements" were reported when people increased from 2,000 steps per day to anywhere between 5,000 and 7,000. "Aiming for 7,000 steps is a realistic goal based on our findings, which assessed health outcomes in a range of areas that hadn't been looked at before," said Professor Ding in the release. "However, for those who cannot yet achieve 7,000 steps a day, even small increases in step counts, such as increasing from 2,000 to 4,000 steps a day, are associated with significant health gain." For those who are already very active and consistently hitting 10,000+ steps, Ding said, "keep it up — there's no need to cut back." The researchers also noted that stepping doesn't need to happen all at once or require intentional exercise. "Everyday movements count — like getting off the bus a stop earlier or choosing stairs over elevators," Ding advised. "Small, incidental bouts throughout the day add up and contribute to health. Embrace opportunities to move more in practical, enjoyable ways." There were some limitations in the study, the researchers noted. "For some outcomes, we have a small number of studies," Ding told Fox News Digital. There are also some study-level biases, she said. "For example, people who are already unwell will take fewer steps because of their health conditions," Ding said. "And while there is an indication that the dose-response may be different for older adults, we didn't have enough data for all outcomes to explore it." It's also important to note that while walking offers great health benefits, it is not a complete "package" in itself, she noted. "Everyday movements count — like getting off the bus a stop earlier or choosing stairs over elevators." "Try to also incorporate strength training and mobility exercise into a weekly routine for more complete health benefits." In next steps, the researchers plan to use these findings to shape future physical activity guidelines. For more Health articles, visit Experts recommend that future studies of step count impacts should focus on variations for age, health status and region, the release stated. "Our research helps to shift the focus from perfection to progress," Ding said. "Even small increases in daily movement can lead to meaningful health improvements."
Yahoo
3 hours ago
- Yahoo
Brains Aged Faster In 2021–2022: What Did The Pandemic Do To Us?
A new study suggests that the pandemic may have had a significant impact on our brains, whether or not we contracted COVID-19. Leveraging an extensive database of brain scans, British researchers say that people's brains showed accelerated aging during 2021 and 2022, including signs of shrinkage. While people who were infected with COVID also showed cognitive decline, like slower processing speed, the study was notable because it said even the non-infected were likely to experience harm to their brain. While the study did not delve into the exact causes of the accelerated aging, the study's first author, Ali-Reza Mohammadi-Nejad, a neuroimaging researcher at the University of Nottingham, theorizes that it may have been the result of stress and other factors. 'But it is likely that the cumulative experience of the pandemic—including psychological stress, social isolation, disruptions in daily life, reduced activity and wellness—contributed to the observed changes… In this sense, the pandemic period itself appears to have left a mark on our brains, even in the absence of infection,' said Mohammadi-Nejad, per NBC. The researchers found that males and 'those from more socioeconomically deprived backgrounds' experienced the most significant brain aging. Overall, the pandemic was thought to be linked to a 5.5-month acceleration in the aging process. This is not the first time researchers have reached similar conclusions. Last year, a previous study found that teenagers experienced dramatic brain aging during the pandemic. Notably, the study suggested that girls' brains aged 4.2 years faster and boys' brains aged 1.3 years faster, on average. The latest study does not indicate whether the structural changes identified in individuals who have never contracted COVID will result in any noticeable changes in brain function. Nor does the study confirm whether the physical changes will persist over the long term, says Adam Brickman, a professor of neuropsychology at Columbia University Vagelos College of Physicians and Surgeons, who was not involved in the study.
